India's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck. Industry sources said the company had put in its bid on......
Germany-based Merck KGaA, the world's oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands. This is part of......
Glenmark Pharmaceuticals is set to earn euro190 million (Rs 1,077.5 crore) from Merck KGaA by licensing the German major to develop a diabetes drug.The deal, which is being dubbed as another......
The German drug multinational, Merck KGaA, which received the Indian marketing approval for its head and neck cancer drug Erbitux last month,plans to conductfirst cancer vaccine trials in India.......
Ranbaxy Laboratories Ltd is eyeing German multinational Merck KGaA's $2.3-billion generic drug business. A deal will make the company the third largest generic drug manufacturer in the world, with......